Critical insights into the evolving drug‐approval process in China is a research paper published in Cancer (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: UG1 CA233198
NCI NIH HHS
Grant: U10 CA180888
MeSH Terms